Brahim Ouahzizi
Research Subjects
Brahim Ouahzizi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Hamza Elbouny
Laboratory of Biochemistry, Department of Biology, Faculty of Sciences and Technology, University Moulay Ismail, Errachidia, Morocco
6 shared publications - Chakib Alem
Moulay Ismail University
5 shared publications - Khalid Sellam
Moulay Ismail University
5 shared publications - Eimad Dine Tariq Bouhlali
Regional Center of Agricultural Research of Errachidia, National Institute of Agricultural Research, Rabat, Morocco
2 shared publications - Mohamed Bammou
Biology, Environment and Health Team, Faculty of Sciences and Technologies, Moulay Ismail University, Meknes 50070, Morocco
2 shared publications - Abdelmonaim Homrani Bakali
Regional Centre of Agricultural Research of Tangier, National Institute of Agricultural Research (INRA), Rabat Principale, Rabat, Morocco
1 shared publication
Latest Publications
- 7 January 2025
- Published by Bentham Science Publishers Ltd. in Current Drug Therapy
- Vol. 18, 1
WITHDRAWN: Antioxidant Potential of Thymus willdenowii Boiss & Reut. Aqueous Extract and Effect of its Supplementation on Hyperlipidemia and Paraoxonase-1 Arylesterase Activity in High-fat Diet-fed Rats
Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article has been withdrawn from the journal Current Drug Therapy. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php BENTHAM SCIENCE DISCLAIMER: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
- 7 January 2025
- Published by Bentham Science Publishers Ltd. in Current Drug Therapy
- Vol. 18, 1
WITHDRAWN: Antioxidant Potential of Thymus willdenowii Boiss & Reut. Aqueous Extract and Effect of its Supplementation on Hyperlipidemia and Paraoxonase-1 Arylesterase Activity in High-fat Diet-fed Rats
Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article has been withdrawn from the journal Current Drug Therapy. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php BENTHAM SCIENCE DISCLAIMER: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
- Open Access
- 26 March 2024
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 11, 10-20
Ethnobotanical survey of medicinal plants claimed by traditional herbal practitioners to manage digestive disorders in an oasis of Tafilalet-Morocco
To highlight the different medicinal plants traditionally used by the local citizens of the Tafilalet region to treat digestive disorders, floristic and ethnobotanical research was conducted in that region from April 2021 to July 2021. The ethnobotanical surveys were carried out using questionnaire sheets with 30 herbalists in different areas in Tafilalet (Errachidia, Rissani, and Erfoud). This study enabled us to gather extensive information about local traditions of therapeutic practices using medicinal plants on one hand and to make a floristic catalog of the same plants on the other hand. Thus, this work ended up by identifying 48 species belonging to 28 floristic families in which Apiaceae and Lamiaceae are the most dominant, and the Ranunculaceae exhibited the highest family use value (FUV=0.667). Of the species listed, Nigella sativa L. has the highest use value (UVs=0.677). The highest relative citation frequency is noted for Rosmarinus officinalis L. and Nigella sativa (RFC=0.233). The leaves (29.82%) are the most used part of plants, and a large part of the remedies are used in powder form (35%) and infusion (28%). The most treated digestive disorders are gastritis (26%) and abdominal pain (24%).
- 26 March 2024
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 11, 10-20
Open AccessEthnobotanical survey of medicinal plants claimed by traditional herbal practitioners to manage digestive disorders in an oasis of Tafilalet-Morocco
To highlight the different medicinal plants traditionally used by the local citizens of the Tafilalet region to treat digestive disorders, floristic and ethnobotanical research was conducted in that region from April 2021 to July 2021. The ethnobotanical surveys were carried out using questionnaire sheets with 30 herbalists in different areas in Tafilalet (Errachidia, Rissani, and Erfoud). This study enabled us to gather extensive information about local traditions of therapeutic practices using medicinal plants on one hand and to make a floristic catalog of the same plants on the other hand. Thus, this work ended up by identifying 48 species belonging to 28 floristic families in which Apiaceae and Lamiaceae are the most dominant, and the Ranunculaceae exhibited the highest family use value (FUV=0.667). Of the species listed, Nigella sativa L. has the highest use value (UVs=0.677). The highest relative citation frequency is noted for Rosmarinus officinalis L. and Nigella sativa (RFC=0.233). The leaves (29.82%) are the most used part of plants, and a large part of the remedies are used in powder form (35%) and infusion (28%). The most treated digestive disorders are gastritis (26%) and abdominal pain (24%).
- Open Access
- 1 January 2024
- Published by International Journal of Secondary Metabolite in International Journal of Secondary Metabolite
- Vol. 11 (1) , 37-47
Phytochemical study and biological activities of Teucrium mideltense (Batt.) Humbert.
Teucrium mideltense (Batt.) Humbert (T. mideltense) is an endemic Moroccan species that grows exclusively in the Oriental High Atlas Mountains of Morocco. In this work, we aim at determining the chemical profile and biological properties of the traditionally used aqueous extract of this plant. HPLC analysis, estimation of the amounts of total phenolic compounds including flavonoids, and in vitro antioxidant activity was evaluated according to the literature procedures (DPPH, ABTS, and FRAP). Additionally, safety assessment was carried out according to the organization for economic cooperation and development guidelines and the anti-hyperlipidemic activity was evaluated in triton-induced hyperlipidemic rat model. Our findings revealed that the aqueous extract of this plant contains significant amounts of phenolic compounds (91.94 mg GAE/gE) including flavonoids (27.41 mg RE/gE). HPLC analysis revealed the presence of vanillic acid, hesperidin, and rutin. Moreover, a considerable in vitro antioxidant effect was evaluated (DPPH IC50 = 36.10± 0.02 μg/mL; ABTS IC50 = 34.98± 1.31 μg/mL; FRAP EC50 = 129.74±2.18 μg/mL). Furthermore, T. mideltense (Batt.) Maire extract exerted significant lipid-lowering effects by reducing the levels of total cholesterol (-88.78%), triglycerides (-62.12%), and non-HDL cholesterol (-68.37%). We conclude that the supplementation with the aqueous extract of T. mideltense would be effective in lowering lipids under hyperlipidemic conditions.
- 1 January 2024
- Published by International Journal of Secondary Metabolite in International Journal of Secondary Metabolite
- Vol. 11 (1) , 37-47
Open AccessPhytochemical study and biological activities of Teucrium mideltense (Batt.) Humbert.
Teucrium mideltense (Batt.) Humbert (T. mideltense) is an endemic Moroccan species that grows exclusively in the Oriental High Atlas Mountains of Morocco. In this work, we aim at determining the chemical profile and biological properties of the traditionally used aqueous extract of this plant. HPLC analysis, estimation of the amounts of total phenolic compounds including flavonoids, and in vitro antioxidant activity was evaluated according to the literature procedures (DPPH, ABTS, and FRAP). Additionally, safety assessment was carried out according to the organization for economic cooperation and development guidelines and the anti-hyperlipidemic activity was evaluated in triton-induced hyperlipidemic rat model. Our findings revealed that the aqueous extract of this plant contains significant amounts of phenolic compounds (91.94 mg GAE/gE) including flavonoids (27.41 mg RE/gE). HPLC analysis revealed the presence of vanillic acid, hesperidin, and rutin. Moreover, a considerable in vitro antioxidant effect was evaluated (DPPH IC50 = 36.10± 0.02 μg/mL; ABTS IC50 = 34.98± 1.31 μg/mL; FRAP EC50 = 129.74±2.18 μg/mL). Furthermore, T. mideltense (Batt.) Maire extract exerted significant lipid-lowering effects by reducing the levels of total cholesterol (-88.78%), triglycerides (-62.12%), and non-HDL cholesterol (-68.37%). We conclude that the supplementation with the aqueous extract of T. mideltense would be effective in lowering lipids under hyperlipidemic conditions.
- 21 August 2023
- Published by Taylor & Francis in Journal of Herbs, Spices & Medicinal Plants
- Vol. 30 (1) , 26-38
Thymus atlanticus Supplementation Attenuates Hepatic Steatosis in High-Fat Diet Fed Guinea Pigs
- 21 August 2023
- Published by Taylor & Francis in Journal of Herbs, Spices & Medicinal Plants
- Vol. 30 (1) , 26-38
Thymus atlanticus Supplementation Attenuates Hepatic Steatosis in High-Fat Diet Fed Guinea Pigs
- 26 March 2023
- Published by International Journal of Secondary Metabolite in International Journal of Secondary Metabolite
- Vol. 10 (1) , 48-58
In vitro investigations of biological activities of Thymus willdenowii and Thymus atlanticus polyphenol-rich extracts
Thyme species produce a wide variety of phenolic compounds including tannins, phenolic acids, and flavonoids. Thymus atlanticus (T. atlanticus) and Thymus willdenowii (T. willdenowii) are important thyme species in the southeast of Morocco, with numerous biological properties. The polyphenolic extracts of these two thyme species were obtained using ethanol through Soxhlet apparatus. Antioxidant (DPPH, FRAP, and TAC methods), antihemolytic (2,2'-Azobis(2-amidinopropane) dihydrochloride (AAPH) induced hemolysis test), hypolipidemic (3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity inhibition test), and anti-inflammatory (protein denaturation inhibition) effects of extracts were carried out using in vitro methods. The results showed that the polyphenolic extracts of these two species revealed important amounts of phenolic compounds. The contents of flavonoids were significant in the two species, while the contents of tannins and anthocyanin were very low. T. atlanticus showed an important antioxidant activity and a considerable antihemolytic effect in AAPH-induced hemolysis test (IC50 = 0.29 mg/mL), while T. willdenowii showed an important anti-inflammatory activity in heat-induced protein denaturation test (IC50 = 1.61 mg/mL). Moreover, both extracts at a dose of 20 µg/mL showed an important in vitro hypolipidemic activity by inhibiting HMG-CoA reductase activity (T. willdenowii: 51.16 %; T. atlanticus: 62.83 %). In conclusion, T. willdenowii and T. atlanticus extracts have considerable antioxidant, antihemolytic, hypolipidemic, and anti-inflammatory effects. The richness of these species in polyphenols gives them a large specter of biological properties, making them a valuable source of natural bioactive compounds that could prevent or treat various diseases.
- 26 March 2023
- Published by International Journal of Secondary Metabolite in International Journal of Secondary Metabolite
- Vol. 10 (1) , 48-58
In vitro investigations of biological activities of Thymus willdenowii and Thymus atlanticus polyphenol-rich extracts
Thyme species produce a wide variety of phenolic compounds including tannins, phenolic acids, and flavonoids. Thymus atlanticus (T. atlanticus) and Thymus willdenowii (T. willdenowii) are important thyme species in the southeast of Morocco, with numerous biological properties. The polyphenolic extracts of these two thyme species were obtained using ethanol through Soxhlet apparatus. Antioxidant (DPPH, FRAP, and TAC methods), antihemolytic (2,2'-Azobis(2-amidinopropane) dihydrochloride (AAPH) induced hemolysis test), hypolipidemic (3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity inhibition test), and anti-inflammatory (protein denaturation inhibition) effects of extracts were carried out using in vitro methods. The results showed that the polyphenolic extracts of these two species revealed important amounts of phenolic compounds. The contents of flavonoids were significant in the two species, while the contents of tannins and anthocyanin were very low. T. atlanticus showed an important antioxidant activity and a considerable antihemolytic effect in AAPH-induced hemolysis test (IC50 = 0.29 mg/mL), while T. willdenowii showed an important anti-inflammatory activity in heat-induced protein denaturation test (IC50 = 1.61 mg/mL). Moreover, both extracts at a dose of 20 µg/mL showed an important in vitro hypolipidemic activity by inhibiting HMG-CoA reductase activity (T. willdenowii: 51.16 %; T. atlanticus: 62.83 %). In conclusion, T. willdenowii and T. atlanticus extracts have considerable antioxidant, antihemolytic, hypolipidemic, and anti-inflammatory effects. The richness of these species in polyphenols gives them a large specter of biological properties, making them a valuable source of natural bioactive compounds that could prevent or treat various diseases.
- Open Access
- 12 March 2022
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 9 (2) , 399-404
Pharmacological, biological and phytochemical aspects of Thymus munbyanus Boiss. & Reut.: A review
Thymus munbyanus Boiss. & Reut., is a small shrub endemic to Morocco and Algeria, and it is commonly used to treat several diseases, including digestive, circulatory, genital, skin, urinary, nervous and respiratory diseases. The extracts of this thyme are rich in a wide variety of phenolic compounds such as polyphenols and volatile phenols and exhibit numerous biological activities. The present review summarizes the literature investigations reported on Thymus munbyanus concerning various pharmacological and biological properties as well as phytochemical aspects. This species revealed a richness in phenolic compounds in its volatile oils, including thymol and carvacrol, as well as in its non-volatile extracts including phenolic acids phenolic acids (rosmarinic acid, caffeic acid, salvianolic acid, ferulic acid, etc.), flavonoids (luteolin, gallocatechin, quercetin, isorhamnetin, etc.). Moreover, powerful antioxidant and antimicrobial properties were reported for this Thymus species, which are attributed to its richness in bioactive antioxidants. Furthermore, this thyme was found to possess important nephroprotective, hepatoprotective, and tumor cytotoxic properties. In conclusion, Thymus munbyanus is an important natural source of bioactive phenolic compounds that can be used for developing alternative natural drugs for the treatment and prevention of several pathologies.
- 12 March 2022
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 9 (2) , 399-404
Open AccessPharmacological, biological and phytochemical aspects of Thymus munbyanus Boiss. & Reut.: A review
Thymus munbyanus Boiss. & Reut., is a small shrub endemic to Morocco and Algeria, and it is commonly used to treat several diseases, including digestive, circulatory, genital, skin, urinary, nervous and respiratory diseases. The extracts of this thyme are rich in a wide variety of phenolic compounds such as polyphenols and volatile phenols and exhibit numerous biological activities. The present review summarizes the literature investigations reported on Thymus munbyanus concerning various pharmacological and biological properties as well as phytochemical aspects. This species revealed a richness in phenolic compounds in its volatile oils, including thymol and carvacrol, as well as in its non-volatile extracts including phenolic acids phenolic acids (rosmarinic acid, caffeic acid, salvianolic acid, ferulic acid, etc.), flavonoids (luteolin, gallocatechin, quercetin, isorhamnetin, etc.). Moreover, powerful antioxidant and antimicrobial properties were reported for this Thymus species, which are attributed to its richness in bioactive antioxidants. Furthermore, this thyme was found to possess important nephroprotective, hepatoprotective, and tumor cytotoxic properties. In conclusion, Thymus munbyanus is an important natural source of bioactive phenolic compounds that can be used for developing alternative natural drugs for the treatment and prevention of several pathologies.